Innovations Transforming The Rheumatoid Arthritis Market

σε πρόσθεσε στο Health

2026-07-22 09:17:12 - Μετάφραση -

The Rheumatoid Arthritis Market outlook remains exceptionally positive as novel mechanism pipelines mature and reach pivotal clinical milestones. With Novartis receiving FDA approval for remibrutinib as a BTK inhibitor and Johnson & Johnson's nipocalimab gaining traction as an FcRn antagonist, the prospect of new oral and injectable options for refractory patients is drawing closer to...

0 Σχόλια 0 Μοιράστηκε 130 Views 0 Προεπισκόπηση